- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02181894
Identifying the Most Accurate Method for Predicting the Safe Depth of Orally Placed Neonatal Endotracheal Tubes (ETT).
Identifying the Most Accurate Method for Predicting the Safe Depth of Orally Placed Neonatal Endotracheal Tubes.
Placing artificial airways in infants is often performed under emergent life-saving conditions, which necessitates a procedure that is both accurate and efficient. Intubations of the newborn are often necessary before an accurate weight can be reported and estimations are often inaccurate. The current national standard uses body weight to predict the appropriate tube depth yet this approach tends to place the tube too deep for the smallest and most vulnerable neonate; and placement accuracy of any size infant is only 50-70%. The consequence of malpositioned ETTs resulting from poor oxygenation, lung hyperinflation, pneumothoraces and death has been suggested to cost $20 to $54 million annually.
The morbidity and the financial impact suggest an optimal and accurate approach to place ETT in neonates has not been identified. Other methods to estimate the proper depth of the orotracheal tube have shown promise yet no comparison studies have been performed. Identifying the most accurate method to safely place neonatal orotracheal tubes will improve placement precision and reduce adverse events and their associated costs.
Hypothesis
Compared to weight, sternal to xyphoid length and shoulder to elbow length, the nasal to tragus length will become the most accurate method for predicting the safe depth of orally placed neonatal endotracheal tubes.
Study Overview
Status
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Dublin 1, Ireland
- The Rotunda Hospital
-
Dublin 8, Ireland
- The Coombe Women & Infants University Hospital
-
-
-
-
California
-
Los Angeles, California, United States, 90027
- Kaiser Permanente, Los Angeles Medical Center
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Children's Hospital Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Infants orally intubated and admitted into the Neonatal Intensive Care Unit.
Exclusion Criteria:
- Previous intubation
- Hydrops fetalis
- Thoracic congenital anomalies
- Facial abnormalities
- Naso-tracheal intubation
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Orally intubated infants
Subjects will be <72 hours of age and orally intubated.
Following consent, four measures will be reported (i.e.
body weight, nasal to tragus length, suprasternal notch to xyphoid process and shoulder to elbow length).
Measures will be compared against a chest x-ray and placement of ETT at the subjects lip to identify the most accurate method to place endotracheal tubes in the newborn.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The differences between 4 measurement methods in placing a neonatal ETT between the lower border of T1 and upper margin of T3 on chest radiograph.
Time Frame: Up to 3 years
|
Up to 3 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The differences in head position in placing a neonatal ETT between the lower border of T1 and upper margin of T3 on chest radiograph.
Time Frame: Up to 3 years
|
Up to 3 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Susan L Moran, DNP APRN NNP-BC FFNMRCSI, Children's Hospital Colorado
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-1117
- UL1TR001082 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventilator Adverse Event
-
Sunnybrook Health Sciences CentreTerminatedVentilator Adverse EventCanada
-
Xuanwu Hospital, BeijingUnknown
-
Nantes University HospitalUniversité de NantesNot yet recruiting
-
Université du Québec à Trois-RivièresCompleted
-
Universidad Miguel Hernandez de ElcheFundación para el Fomento de la Investigación Sanitaria y Biomédica de la...Active, not recruiting
-
Hospices Civils de LyonUnknown
-
Lucie HeinzerlingRecruitingImmune-related Adverse EventGermany
-
China National Center for Cardiovascular DiseasesShanghai Zhongshan Hospital; First Affiliated Hospital Xi'an Jiaotong University and other collaboratorsCompletedHemocompatibility-related Adverse EventChina
-
Quanli GaoRecruiting
-
Chang Gung Memorial HospitalMinistry of Science and Technology, TaiwanRecruitingImmune-related Adverse EventTaiwan